| ²é¿´: 904 | »Ø¸´: 6 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
25332135Òø³æ (СÓÐÃûÆø)
|
[½»Á÷]
Ïã¸Û´óѧÑо¿·¢ÏÖÄÉÃ×Òø¿ÅÁ£ÄÜÒÖÖÆÒҸβ¡¶¾
|
||
|
Ïã¸Û´óѧÑо¿·¢ÏÖÄÉÃ×Òø¿ÅÁ£ÄÜÒÖÖÆÒҸβ¡¶¾ 2008Äê04ÔÂ29ÈÕ 08:58 À´Ô´£ºÐ»ªÍø Ïã¸Û´óѧ28ÈÕ¹«²¼µÄÒ»ÏîÑо¿½á¹ûÏÔʾ£¬ÄÉÃ×Òø¿ÅÁ£ÄÜÒÖÖÆÒÒÐ͸ÎÑײ¡¶¾µÄ¸´ÖÆ£¬½µµÍÒҸλ¼Õ߸ÎÓ²»¯µÄ¼¸ÂÊ¡£×¨¼ÒÔ¤¼Æ£¬Î´À´3ÖÁ5ÄêÕâÒ»³É¹û¾Í¿É½øÐÐÁÙ´²ÊµÑé¡£ Ïã¸Û´óѧҽѧԺÑо¿ÈËÔ±3Äêǰ¿ªÊ¼½øÐÐÄÉÃ×Òø¿ÅÁ£ÒÖÖÆÒҸβ¡¶¾»úÀíºÍ¸´ÖÆ»îÐÔµÄÑо¿£¬½á¹û֤ʵÄÉÃ×Òø¿ÅÁ£¿ÉÖ±½ÓÓëÒҸβ¡¶¾·¢Éú×÷Óã¬ÒÖÖÆ²¡¶¾µÄ¸´ÖÆ¡£ Ïã¸Û´óѧҽѧԺÄÚ¿ÆÑ§Ïµ½ÌÊÚÁμҽÜ˵£¬ÄÉÃ×Òø¿ÅÁ£µÄ±íÃæ»îÐÔÃæ»ý½Ï´ó£¬ÈÝÒ׺ÍÒҸβ¡¶¾½áºÏ£¬´Ó¶øÒÖÖÆ²¡¶¾¸´ÖÆ£¬¼õÉÙ²¡¶¾ÊýÁ¿£¬¶øÒҸβ¡¶¾¶ÔÕâÒ»Á¬´®»úÀí²úÉú¿¹Ò©ÐԵĻú»á΢ºõÆä΢¡£ Áμҽܱíʾ£¬Ô¤¼ÆÄÉÃ×Òø¿ÅÁ£ÖÎÁÆÒÒ¸ÎÔÚδÀ´3ÖÁ5Äê¿É½øÐÐÁÙ´²ÊµÑé¡£ ¸Û´óÑз¢ÄÉÃ×Òø¿ÅÁ£Ò½ÒÒ¸ÎÒ»¸öСʱºóɱ¶¾9³É À´Ô´£ºÖйúÐÂÎÅÍø ×÷ÕߣºÀî¼û°² ¡¡¡¡Áμҽܱíʾ£¬ÄÉÃ×Òø¿ÅÁ£ÄÜÒÖÖÆÒҸβ¡¶¾¸´ÖƼ°×èÖ¹²¡¶¾½øÈë¸Îϸ°û¡£ ¡¡¡¡ÎÚ³ľÆëÔÚÏßѶÏã¸ÛÔ¼ÓÐ70ÍòÈËÊÇÒÒÐ͸ÎÑ×´ø¾úÕß¡£Ïã¸Û´óѧÀî¼Î³ÏҽѧԺ·¢ÏÖ£¬°Ñ¼«Î¢Ï¸µÄ¡°ÄÉÃ×Òø¿ÅÁ£¡±×¢Éä½ø²¡ÈËÌåÄÚºó£¬ÒøÁ£»áÒÀ¸½ÔÚÒÒÐ͸ÎÑײ¡¶¾ÉÏÒÔÒÖÖÆ²¡¶¾¸´ÖÆ£¬10·ÖÖÓÄڿɼõÉÙ40%²¡¶¾£¬1Сʱºó¿ÉʹԼ90%²¡¶¾Ïûʧ£¬»¼Õß½üºõȬÓú£¬¶øÇÒ²»»á³öÏÖ¿¹Ò©ÐÔ¡£Ò½Ñ§Ôº¹À¼Æ£¬Í¨¹ýÒ©Îï¡¢¶¯ÎïµÈ²âÊÔºó£¬×î¿ì3ÖÁ5Äêºó¿ÉÒÔÁÙ´²Ó¦Óᣠ¡¡¡¡¾ÝÏã¸ÛÎĻ㱨±¨µÀ£¬¸Û´óҽѧԺÄÚ¿ÆÑ§ÏµºÍÀíѧԺ»¯Ñ§Ïµ¾¹ý3ÄêµÄÑо¿£¬·¢ÏÖ¡°ÄÉÃ×Òø¿ÅÁ£¡±¿ÉÓÐЧÒÖÖÆÒҸβ¡¶¾¸´ÖÆ¡£¸Û´ó΢ÉúÎïѧϵÖúÀí½ÌÊÚÐíÖ¾¼á½âÊÍ£¬ÄÉÃ×Òø¿ÅÁ£Óнϴó±íÃæ»îÐÔÃæ»ýºÍ¶à¿×ÐÔ£¬¿ÉÓëС·Ö×ÓÏ໥½áºÏ¡£Ñо¿ÈËÔ±°Ñƽ¾ùÖ±¾¶½ö5ÖÁ50ÄÉÃ×µÄÒø¿ÅÁ£(100ÍòÄÉÃ×=1ºÁÃ×)£¬×¢È벡ÈËÌåÄÚ£¬ÒøÁ£±ã»áÒÀ¸½ÔÚÒҸβ¡¶¾ÉÏ¡£ ¡¡¡¡Ö»Ðè2Ì첡¶¾½µÖÁ½üÁã ¡¡¡¡Ñо¿·¢ÏÖ£¬ÔÚ×¢ÉäÄÉÃ×Òø¿ÅÁ£½ö10·ÖÖÓºó£¬ÒѼõÉÙ40%ÒҸβ¡¶¾£¬1СʱºóÔ¼90%µÄÒҸβ¡¶¾ÒÑÏûʧ¡£¸ºÔðÑо¿µÄҽѧԺÖúÀíÔº³¤¼°ÄÚ¿ÆÑ§Ïµ¸ÎÔಡѧ½ÌÊÚÁμҽܽâÊÍ£¬ÒҸβ¡¶¾»á²»¶Ï¸´ÖÆ£¬ÄÉÃ×Òø¿ÅÁ£¿ÉÒÖÖÆÒҸβ¡¶¾¸´ÖƼ°×èÖ¹²¡¶¾½øÈë¸Îϸ°û£¬ÏàÐÅÖ»Ðè2Ì죬±ãÄܰÑÒҸβ¡¶¾½µÖÁ¼¸ºõÁ㣻µ±È»£¬»¼ÕßÄÜ·ñÍêÈ«¿µ¸´£¬ÈÔÐëÊÓºõÆäÃâÒßϵͳ¹¦ÄÜ¡£ ¡¡¡¡ÄÉÃ×Òø¿ÅÁ£µÄÑо¿£¬ÒÑÓÚ×îÐÂÒ»ÆÚµÄ¹ú¼ÊÖøÃû¿¹²¡¶¾Ñо¿ÔÓÖ¾¡¶Antiviral Therapy¡·ÉÏ·¢±í¡£Áμҽܱíʾ£¬ÒòÄÉÃ×Òø¿ÅÁ£ÊÇÎïÀíÉϵĻúÀí£¬ÒҸλ¼Õß³öÏÖ¿¹Ò©ÐÔ»ú»á΢ºõÆä΢£»¶øÊÐÃæ5ÖÖÖÎÁÆÂýÐÔÒҸεġ°²¡¶¾ÒÖÖÆ¼Á¡±(ÆäÖÐ1ÖÖ¼´½«ÃæÊÀ)£¬Æä»úÀíÔÚÓÚÒÖÖÆÁîÒҸβ¡¶¾¸´ÖƵĻùÒò¡°×ªÂ¼®Å¡±£¬»¼Õß»á³öÏÖ¿¹Ò©ÐÔ¡£ ¡¡¡¡ÒÖÖÆ²¡¶¾¸´ÖÆÐøÑÐÖθΰ© ¡¡¡¡Áμҽܳƣ¬Ô¼70%»¼Õß·þʳÒÒ¸ÎÒ©Îï¡°ÀÃ×·ò¶¨¡±4ÖÁ5Äêºó»á³öÏÖ¿¹Ò©ÐÔ£»Èô·þÓÃÁíÒ»ÖÖÒ©Îï¡°°¢µÂ¸£Î°¡±5Äêºó£¬ÓÐ29%»¼Õß³öÏÖ¿¹Ò©ÐÔ£»Èô·þÓá°Ë¼Ì濨Τ¡±4Äêºó£¬ÓÐ15%Óп¹Ò©ÐÔ¡£Ëû³Æ£¬Èô³öÏÖ¿¹Ò©ÐÔ£¬¸ÎÔàÏËά»¯¼°¸ÎÓ²»¯µÄ»ú»á¿ÉÉÏÉý1±¶¡£ÈôÑ¡Óá°ÃâÒßµ÷½Ú¼Á¡±£¬ÓÐ10%ÖÁ15%»¼Õß½ÓÊÜ×¢Éäºó»á³öÏÖ¸±×÷Óᣠ¡¡¡¡ÄÉÃ×Òø¿ÅÁ£Ä¿Ç°ÒÑÓ¦ÓÃÓÚһЩƤ·ô²¡¡¢ÉË¿ÚÓúºÏ¼°°¬×̲¡ÉÏ¡£Áμҽܳƣ¬ÄÉÃ×Òø¿ÅÁ£ºÎʱ¿ÉÓ¦ÓÃÓÚÒҸλ¼ÕßÉÏ£¬ÈÔÐèͨ¹ýÒ©Îï¡¢¶¯Îï²âÊÔ¡¢Á˽â¼ÁÁ¿µÈºó£¬ÏàÐÅ×î¿ì3ÖÁ5ÄêÓ¦ÓÃÓÚÁÙ´²ÉÏ£¬µ«ÔÝδ֪Êǿڷþ»òÕë¼Áģʽ¡£ËûÓֳƣ¬ÏÂÒ»²½»áÑо¿ÄÉÃ×¼¼ÊõÓ¦ÓÃÓڸΰ©£¬²¢¹À¼ÆÄÉÃ×¼¼ÊõÔÚδÀ´5ÖÁ10Äê»á¹ã·ºÓ¦ÓÃÓÚҽѧÉÏ¡£ [search]ÒøÄÉÃ׿ÅÁ£ ÒÖÖÆ ÒҸβ¡¶¾[/search] http://www.ce.cn/xwzx/gnsz/gdxw/200804/29/t20080429_15312114.shtml |
» ²ÂÄãϲ»¶
ѧԺ¹Ù·½Èº-ԺʿÍŶÓÕÐÉú-ѧÉú×ÔÓɶȸß-ÅàÑøÄ£Ê½³ÉÊìÒÑÓÐ10ÓàÃûѧÉú¸°985º£ÍâÉîÔì
ÒѾÓÐ0È˻ظ´
Î人·ÄÖ¯´óѧ»¯¹¤Ñ§Ôº¹Ù·½Èº-ԺʿÍŶÓÕÐÉú-ѧÉú×ÔÓɶȸß-10ÓàÃûѧÉú¸°985º£ÍâÉîÔì
ÒѾÓÐ0È˻ظ´
½ðÊô²ÄÁÏÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ215È˻ظ´
Äϲýº½¿Õ´óѧ½¯»ª÷ë½ÌÊÚ¿ÎÌâ×éÕÐÊÕ»¯Ñ§¡¢»·¾³¡¢Ì¼´ï·å̼Öкͼ°Ïà¹Ø×¨ÒµË¶Ê¿ÐÅÏ¢
ÒѾÓÐ0È˻ظ´
ºþ±±Ê¦·¶´óѧ¸´ÊÔµ÷¼Á
ÒѾÓÐ0È˻ظ´
Î人·ÄÖ¯´óѧ_»¯¹¤Ñ§Ôº¹Ù·½µ÷¼ÁȺ-ԺʿÍŶÓÕÐÉú-ѧÉú×ÔÓɶȸß-ÿ½ì·¢Õ¹ºÃ
ÒѾÓÐ0È˻ظ´
ºÓ±±´óѧ²ÄÁÏÓ뻯¹¤×¨ÒµÑо¿Éú£¨×¨Ë¶£©ÕÐÊÕµ÷¼ÁÉú
ÒѾÓÐ0È˻ظ´
ºÓ±±´óѧÎÞ»ú»¯Ñ§×¨ÒµÕÐÊÕµ÷¼ÁÉú
ÒѾÓÐ0È˻ظ´
¼ÃÄÏ´óѧ¹ú¼ÒÓÅÇà¿ÎÌâ×é 2026 µ÷¼ÁÕÐÉúÀ´À²
ÒѾÓÐ0È˻ظ´
Î人·ÄÖ¯´óѧ_»¯Ñ§Ôº¹Ù·½µ÷¼ÁȺ-ԺʿÍŶÓÕÐÉú-ѧÉú×ÔÓɶȸ߷¢Õ¹ºÃ-»¶Ó¸÷λͬѧ
ÒѾÓÐ0È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

aero-silica
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 8 (Ó×¶ùÔ°)
- ½ð±Ò: 697.2
- ºì»¨: 2
- Ìû×Ó: 497
- ÔÚÏß: 25.1Сʱ
- ³æºÅ: 482890
- ×¢²á: 2007-12-26
- ÐÔ±ð: GG
- רҵ: ÎÛȾ¿ØÖÆ»¯Ñ§
3Â¥2008-06-11 21:24:10
25332135
Òø³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 378.3
- ºì»¨: 1
- Ìû×Ó: 204
- ÔÚÏß: 20.1Сʱ
- ³æºÅ: 312134
- ×¢²á: 2006-12-30
- ÐÔ±ð: GG
- רҵ: µç»¯Ñ§
|
In the first-ever study of metal nanoparticles' interaction with HIV-1, silver nanoparticles of sizes 1-10nm attached to HIV-1 and prevented the virus from bonding to host cells. The study, published in the Journal of Nanotechnology, was a joint project between the University of Texas, Austin and Mexico Univeristy, Nuevo Leon. "Our article opens an important avenue for research," said Miguel Jose Yacaman, from University of Texas, Department of Engineering and one of the study's authors. In this study, scientists mixed silver nanoparticles with three different capping agents: foamy carbon, poly (PVP), and bovine serum albumin (BSA)."Not using a capping agent could result in the synthesis of big crystals instead of nanocrystals," explained Yacaman. Transmission electron microscopy (TEM) showed the silver nanoparticles in the foamy carbon matrix were joined together, but an ultrasonic bath in deionized water released a significant number of nanoparticles. These nanoparticles were of size 16.19 (+-8.69)nm and had the greatest variety of shapes, such as icosahedral, decahedral, and elongated. "Because of the synthesis procedure, the foamy carbon-coated naoparticles are more likely to have broad shape distribution," said Yacaman. Scientists used the electron beam to release the remainder of the nanoparticles from the joined bundle. For the PVP-coated silver nanoparticles, scientists used glycerine as a dissolving agent. These particles were of size 6.53 (+-2.41). In the third preparation, scientists used serum albumin, the most common protein in blood plasma. The sulfur, oxygen, and nitrogen chemicals in BSA stabilized the nanoparticles, which were in the range of 3.12 (+-2.00) nm. Scientists studied the absorption spectra of the different preparations to pinpoint their shapes. "Spherical nanoparticles absorbed in the blue region of the spectrum, for example," Yacaman said. Also, the UV-Visible spectra graphs helped the group determine nanoparticle sizes. "The surface plasmon resonance peak wavelength increased with size," explained Yacaman. |

2Â¥2008-06-10 21:04:21
|
±¾ÌûÄÚÈݱ»ÆÁ±Î |
4Â¥2008-06-12 11:53:38
25332135
Òø³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 378.3
- ºì»¨: 1
- Ìû×Ó: 204
- ÔÚÏß: 20.1Сʱ
- ³æºÅ: 312134
- ×¢²á: 2006-12-30
- ÐÔ±ð: GG
- רҵ: µç»¯Ñ§

5Â¥2008-06-15 15:49:37














»Ø¸´´ËÂ¥

